present
studi
multiplex
revers
transcriptas
polymeras
chain
reaction
combin
chip
hybrid
assay
prodect
bc
rv
chip
evalu
altern
combin
immunofluoresc
antibodi
test
shell
vial
cell
cultur
consid
gold
standard
detect
respiratori
virus
among
specimen
posit
use
combin
immunofluoresc
antibodi
test
shell
vial
cell
cultur
assay
infect
two
differ
virus
parainfluenza
viru
type
adenoviru
respiratori
syncyti
viru
influenza
type
b
influenza
type
prodect
bc
rv
chip
detect
posit
specimen
one
infect
two
differ
virus
respiratori
syncyti
viru
parainfluenza
viru
type
adenoviru
influenza
viru
type
b
sensit
specif
ppv
npv
diagnost
accuraci
prodect
bc
rv
chip
respect
compar
combin
shell
vial
cell
cultur
immunofluoresc
antibodi
test
result
specif
prodect
bc
rv
chip
high
howev
sensit
assay
suffici
routin
laboratori
use
infect
human
respiratori
tract
differ
virus
caus
diseas
similar
sign
symptom
clinic
sign
symptom
patient
infect
specif
respiratori
virus
use
differenti
clearli
one
viru
anoth
respect
rapid
specif
identif
infect
viru
provid
mani
advantag
assist
clinician
make
therapeut
decis
prevent
nosocomi
infect
alert
onset
epidem
respiratori
syncyti
viru
rsv
influenza
viru
type
b
adenovirus
parainfluenza
viru
type
caus
vast
major
identifi
viral
respiratori
infect
children
virus
respons
spectrum
acut
upper
lower
respiratori
tract
diseas
major
caus
croup
bronchiol
pneumonia
infant
young
children
howev
virus
may
caus
signific
morbid
mortal
adult
especi
among
elderli
immunocompromis
individu
detect
virus
enabl
take
appropri
measur
prevent
viral
diseas
avoid
unnecessari
antibiot
treatment
thu
allow
proper
use
antivir
drug
coria
et
al
dowel
et
al
henrickson
syrmi
et
al
diagnosi
viral
respiratori
infect
base
use
convent
method
viral
cell
cultur
indirect
immunofluoresc
antibodi
test
ifat
although
method
valuabl
signific
limit
term
sensit
specif
viral
cell
cultur
consid
gold
standard
respiratori
viru
detect
howev
techniqu
limit
due
prolong
result
turnaround
time
rapid
loss
viabil
unsuit
specimen
transport
see
front
matter
elsevi
bv
right
reserv
storag
condit
bellaupujol
et
al
liolio
et
al
syrmi
et
al
ifat
rapid
less
sensit
method
viral
cell
cultur
may
affect
specimen
qualiti
viru
type
incorrect
interpret
result
inexperienc
personnel
past
decad
pcr
techniqu
improv
sensit
specif
detect
respiratori
virus
recent
develop
multiplex
pcr
assay
led
decreas
expens
short
result
turnaround
time
addit
molecular
amplif
method
need
viabl
organ
contrast
viru
cell
cultur
method
requir
viabl
organ
multiplex
pcr
consid
advanc
method
compar
convent
pcr
detect
simultan
one
viru
singl
reaction
bellaupujol
et
al
coria
et
al
liolio
et
al
syrmi
et
al
present
studi
multiplex
revers
transcriptas
polymeras
chain
reaction
combin
chip
hybrid
assay
prodect
bc
rv
chip
compar
ifat
shell
vial
cell
cultur
combin
method
consid
gold
standard
prodect
bc
rv
chip
multiplex
revers
transcriptas
pcr
techniqu
rapidli
detect
differenti
eight
differ
respiratori
virus
influenza
viru
type
b
rsv
adenoviru
parainfluenza
viru
type
sar
cov
method
base
detect
biotinlabel
pcr
amplifi
product
obtain
multiplex
pcr
assay
pcr
product
bind
high
specif
complementari
sequenc
immobil
oligonucleotid
probe
array
nitrocellulos
membran
array
analyz
use
reader
bc
aim
reader
develop
manufactur
bc
biotech
spa
itali
februari
novemb
nasopharyng
swab
specimen
collect
girl
boy
pediatr
femal
male
adult
patient
acut
lower
respiratori
tract
infect
bronchiol
bronchopneumonia
pneumonia
pediatr
adult
patient
age
rate
day
year
median
year
year
median
year
respect
nasopharyng
swab
specimen
transport
laboratori
viral
transport
medium
eurotubo
collect
swab
rubi
spain
within
hour
collect
specimen
ad
ml
medium
contain
minim
essenti
medium
mem
supplement
penicillinstreptomycin
uml
gentamycin
mgml
amphotericin
b
mgml
ifat
shell
vial
cell
cultur
prodect
bc
rv
chip
assay
perform
soon
specimen
arriv
laboratori
remain
specimen
store
c
specimen
vortex
thoroughli
centrifug
rpm
c
min
supernat
kept
shell
vial
cell
cultur
cell
pellet
immedi
resuspend
l
pb
phosphat
buffer
salin
ph
one
hundr
microlit
cell
suspens
place
cytofunnel
cytocentrifug
rpm
min
slide
air
dri
fix
prechil
aceton
min
c
stain
respiratori
viru
panel
ifa
kit
bartel
immunodiagnost
suppli
inc
bellevu
washington
usa
accord
manufactur
protocol
posit
specimen
detect
use
pool
monoclon
antibodi
stain
use
fluorescein
label
monoclon
antibodi
specif
influenza
viru
type
b
rsv
adenoviru
parainfluenza
viru
type
bartel
immunodiagnost
suppli
inc
bellevu
washington
usa
presenc
least
three
cell
typic
stain
consid
posit
nonimmun
mous
antiserum
bartel
immunodiagnost
suppli
inc
bellevu
washington
usa
use
neg
control
exclud
nonspecif
fluoresc
patient
four
shell
vial
contain
human
laryng
carcinoma
cell
nation
public
health
institut
helsinki
finland
four
shell
vial
contain
madin
darbi
canin
kidney
mdck
cell
nation
public
health
institut
helsinki
finland
two
shell
vial
contain
african
green
monkey
kidney
vero
cell
line
german
collect
microorgan
cell
cultur
dsmz
germani
prepar
vial
inocul
ml
specimen
supernat
recoveri
follow
five
respiratori
virus
adenoviru
rsv
influenza
viru
type
b
mdck
parainfluenza
viru
vero
thu
two
vial
prepar
viru
detect
next
vial
centrifug
g
min
c
incub
c
h
supernat
aspir
vial
subsequ
ml
isol
medium
contain
eagl
mem
supplement
fc
antibiot
biochromag
leonorenstr
berlin
germani
ad
vial
contain
vero
cell
ml
serum
free
medium
contain
gml
trypsintpck
applichem
usa
ad
vial
contain
mdck
cell
vial
incub
moist
chamber
c
co
atmospher
h
describ
wiedbrauk
johnston
coverslip
insid
first
set
vial
remov
care
fix
prechil
aceton
min
c
stain
fluorescein
isothiocyn
label
monoclon
antibodi
specif
rsv
parainfluenza
viru
adenoviru
influenza
viru
type
b
light
diagnost
chemicon
intern
usa
accord
manufactur
protocol
coverslip
examin
typic
fluoresc
inclus
bodi
consid
posit
one
fluoresc
inclus
bodi
present
specimen
neg
type
viru
shell
vial
contain
mdck
vero
cell
second
set
shell
vial
incub
day
coverslip
remov
fix
prechil
aceton
stain
fluorescein
isothiocyn
label
monoclon
antibodi
describ
previous
inocul
specimen
take
approxim
day
detect
parainfluenza
viru
shell
vial
cell
cultur
thu
specimen
store
c
meantim
paraifluenza
viru
posit
specimen
thaw
ml
specimen
incub
three
differ
shell
vial
contain
vero
cell
describ
previous
test
presenc
parainfluenza
viru
type
use
fluorescein
isothiocyn
label
monoclon
antibodi
specif
parainfluenza
viru
type
light
diagnost
chemicon
intern
usa
viral
nucleic
acid
extract
ml
specimen
viral
transport
medium
use
high
pure
viral
nucleic
acid
kit
accord
manufactur
protocol
purifi
nucleic
acid
elut
column
use
l
elut
buffer
provid
kit
roch
appli
scienc
germani
prodect
bc
rv
chip
method
multiplex
revers
transcriptas
polymeras
chain
reaction
follow
chip
hybrid
assay
bc
biotech
itali
multiplex
revers
transcriptas
pcr
rtpcr
perform
accord
manufactur
protocol
two
distinct
ml
dnasernasefre
pcr
tube
label
tube
tube
sampl
two
microlit
rtpcr
mix
mix
ad
tube
tube
respect
l
purifi
nucleic
acid
l
readytogo
enzym
mix
rtpcr
bead
amersham
bioscienc
uk
ad
tube
tube
incub
c
min
thermal
cycler
eppendorf
germani
synthes
cdna
pcr
amplif
reaction
prepar
ad
mix
rm
solut
mix
rm
solut
contain
biotin
label
primer
design
highli
conserv
genet
sequenc
eight
respiratori
virus
target
hemagglutinin
neuraminidas
gene
parainfluenza
viru
type
nonstructur
gene
influenza
viru
type
b
nonstructur
gene
rsv
hemagglutinin
gene
adenoviru
fragment
sar
dna
polymeras
tube
pcr
amplif
reaction
perform
thermal
cycler
eppendorf
germani
use
follow
calcul
protocol
min
initi
denatur
step
c
follow
cycl
c
c
c
extens
min
c
biotinyl
amplifi
pcr
product
hybrid
set
eight
immobil
oligonucleotid
probe
bound
coval
nitrocellulos
membran
chip
use
manufactur
protocol
briefli
amplifi
pcr
product
tube
tube
well
l
bc
hyb
buffer
peroxidaselabel
probe
solut
mix
tube
tube
incub
min
c
immedi
chill
ice
min
next
mixtur
transfer
onto
chip
provid
manufactur
incub
c
h
incub
bc
mini
owen
itali
pcr
product
hybrid
oligonucleotid
probe
chip
chip
wash
five
time
l
wash
buffer
provid
kit
incub
strepap
streptavidinalkalin
phosphatas
dilut
block
reagent
min
room
temperatur
wash
l
wash
buffer
min
next
chip
invert
tap
onto
paper
towel
time
remov
residu
liquid
visual
reaction
chip
l
detect
buffer
mix
l
nbtbcip
ad
onto
chip
incub
dark
min
room
temperatur
chip
wash
distil
water
airdri
hybrid
colorimetr
develop
specif
probe
pathogen
present
pcr
product
bind
oligonucleotid
probe
probetarget
hybrid
form
bluepurpl
precipit
chip
develop
pattern
chip
detect
reader
provid
manufactur
bc
reader
bc
biotech
itali
differ
virus
present
specimen
could
distinguish
differ
hybrid
pattern
chip
fig
capvir
method
multiplex
rtpcr
follow
nitrocellulos
strip
hybrid
assay
genom
identif
diagnost
gmbh
gen
id
germani
method
specimen
randomli
select
frozen
specimen
posit
parainfluenza
viru
type
use
shell
vial
cell
cultur
neg
prodect
bc
rv
chip
viral
nucleic
acid
select
thaw
specimen
extract
previous
describ
use
capvir
method
multiplex
rtpcr
perform
accord
manufactur
protocol
specimen
three
group
tube
contain
three
ml
dnasernas
free
pcr
tube
prepar
three
type
reaction
mix
prepar
group
tube
tube
first
group
tube
contain
reaction
mix
prepar
follow
reagent
l
capvir
flu
solut
contain
biotin
label
primer
design
nonstructur
protein
influenza
viru
type
b
l
rtbuffer
l
mm
mn
oac
unit
rnase
inhibitor
unit
tthdna
polymeras
roch
germani
tube
first
group
three
tube
contain
reaction
mix
gentli
mix
l
extract
viral
nucleic
acid
l
rnase
free
distil
h
neg
control
l
microglobulin
amplif
control
extract
rna
cell
respect
tube
second
group
tube
contain
reaction
mix
prepar
follow
reagent
l
capvir
piv
solut
contain
biotin
label
primer
design
hemagglutinin
gene
parainfluenza
viru
type
nucleocapsid
protein
parainfluenza
viru
type
l
rtbuffer
l
mm
mn
oac
unit
rnase
inhibitor
unit
tthdna
polymeras
tube
second
group
three
tube
contain
reaction
mix
mix
gentli
fig
prodect
bc
rv
chip
probe
design
chip
model
repres
prodect
bc
rv
chip
probe
specimen
respiratori
virus
parainfluenza
viru
type
influenza
viru
type
b
adenoviru
respiratori
syncyti
viru
sar
cov
chip
five
control
spot
control
spot
locat
corner
chip
hybrid
control
show
proper
handl
reagent
use
assay
control
spot
locat
centr
chip
amplif
control
target
intern
control
show
amplif
reaction
occur
addit
chip
amplif
control
design
identifi
disturb
effect
inhibitori
substanc
insid
sampl
hamper
amplif
reaction
l
extract
viral
nucleic
acid
l
rnase
free
distil
h
l
microglobulin
respect
tube
third
group
tube
contain
reaction
mix
prepar
follow
reagent
l
capvir
rsvadv
solut
contain
biotin
label
primer
design
hexon
protein
adenoviru
polymeras
gene
rsv
l
rtbuffer
l
mm
mn
oac
unit
rnase
inhibitor
unit
tthdna
polymeras
tube
third
group
three
tube
contain
reaction
mix
mix
gentli
l
extract
viral
nucleic
acid
l
rnase
free
distil
h
l
microglobulin
respect
pcr
amplif
reaction
perform
thermal
cycler
eppendorf
germani
use
follow
calcul
protocol
cycl
min
c
min
c
follow
cycl
c
c
c
final
extens
min
c
biotinyl
amplifi
pcr
product
hybrid
set
seven
immobil
oligonucleotid
probe
bound
coval
nitrocellulos
strip
use
manufactur
protocol
briefli
l
amplifi
pcr
product
collect
tube
contain
viral
nucleic
acid
mix
well
incub
tray
sixti
microlit
denatur
agent
ad
well
gentli
mix
incub
min
room
temperatur
one
microlit
prewarm
hybrid
buffer
ad
well
strip
transfer
well
contain
mixtur
tray
contain
strip
incub
min
c
shake
water
bath
memmert
pro
scientif
inc
germani
next
hybrid
buffer
discard
strip
wash
twice
quickli
ml
prewarm
wash
solut
room
temperatur
horizont
shaker
provid
manufactur
strip
wash
ml
prewarm
wash
solut
min
c
shake
water
bath
strip
wash
twice
rins
solut
one
min
horizont
shaker
room
temperatur
strip
incub
ml
conjug
dilut
conjug
buffer
min
horizont
shaker
room
temperatur
wash
three
time
ml
rins
ii
solut
min
room
temperatur
visual
reaction
strip
ml
substrat
solut
ad
strip
incub
dark
min
room
temperatur
reaction
stop
wash
strip
twice
ml
distil
water
strip
transfer
absorb
paper
air
dri
dark
neg
amplif
control
l
sampl
collect
group
correspond
neg
amplif
control
tube
mix
two
differ
well
incub
tray
sixti
microlit
denatur
agent
ad
well
capvir
nitrocellulos
strip
hybrid
method
perform
describ
therefor
end
assay
three
strip
contain
viral
nucleic
acid
neg
amplif
control
prepar
specimen
band
strip
analyz
use
suppli
templat
provid
manufactur
fig
sensit
specif
posit
neg
predict
valu
diagnost
accuraci
calcul
use
standard
method
dawsonsaund
trapp
shown
tabl
group
pediatr
patient
posit
respiratori
virus
fig
interpret
result
capvir
method
strip
present
figur
nitrocellulos
strip
templat
use
analys
result
capvir
method
strip
conjug
control
band
appear
effici
conjug
bind
occur
amplif
control
zone
strip
probe
mrna
code
sequenc
microglobulin
serv
marker
human
mrna
develop
appropri
rna
extract
rtpcr
repres
strip
probe
neg
control
conjug
band
appear
b
repres
strip
probe
amplif
control
conjug
amplif
control
band
appear
c
repres
strip
probe
specimen
parainfluenza
viru
type
influenza
viru
type
b
adenoviru
respiratori
syncyti
viru
conjug
band
amplif
band
band
specif
virus
appear
specif
control
zone
strip
develop
wash
temperatur
low
show
unspecif
hybrid
group
adult
patient
patient
posit
respiratori
virus
parainfluenza
viru
type
detect
studi
thu
respiratori
virus
isol
identifi
specimen
obtain
patient
tabl
present
studi
ifat
shell
vial
cell
cultur
prodect
bc
rv
chip
method
perform
specimen
capvir
method
carri
specimen
randomli
select
frozen
specimen
posit
parainfluenza
viru
type
use
shell
vial
cell
cultur
neg
prodect
bc
rv
chip
respiratori
viru
posit
specimen
ifat
detect
respiratori
virus
specimen
five
dual
viru
infect
singl
viru
infect
therefor
respiratori
virus
detect
specimen
use
ifat
shell
vial
cell
cultur
detect
respiratori
virus
specimen
five
dual
viru
infect
thu
virus
detect
specimen
use
shell
vial
cell
cultur
last
assay
prodect
bc
rv
chip
detect
respiratori
virus
specimen
one
dualli
infect
eleven
respiratori
virus
detect
specimen
prodect
bc
rv
chip
method
combin
ifat
shell
vial
cell
cultur
consid
gold
standard
present
studi
detect
respiratori
virus
specimen
dual
viru
infect
singl
viru
infect
specimen
respiratori
virus
detect
use
combin
ifat
shell
vial
cell
cultur
result
shell
vial
cell
cultur
ifat
prodect
bc
rv
chip
detect
respiratori
virus
specimen
respect
addit
prodect
bc
rv
chip
detect
one
dual
infect
compar
combin
ifat
shell
vial
cell
cultur
detect
nine
dual
infect
tabl
sensit
prodect
bc
rv
chip
detect
rsv
adenoviru
parainfluenza
viru
type
respect
specif
virus
influenza
viru
type
b
detect
small
group
specimen
n
studi
prodect
bc
rv
chip
result
compar
shell
vial
cell
cultur
ifat
overal
sensit
specif
posit
predict
valu
ppv
neg
predict
valu
npv
diagnost
accuraci
prodect
bc
rv
chip
respect
compar
combin
ifat
shell
vial
cell
cultur
ten
specimen
parainfluenza
viru
type
posit
shell
vial
cell
cultur
neg
prodect
bc
rv
chip
assay
also
posit
parainfluenza
viru
type
use
capvir
method
inhibitori
substanc
detect
specimen
prodect
bc
rv
chip
capvir
method
one
wide
use
method
diagnosi
viral
respiratori
infect
isol
virus
shell
vial
cell
cultur
immunofluoresc
antibodi
test
halstead
et
al
henrickson
even
though
method
effect
often
complementari
disadvantag
cell
cultur
techniqu
consid
tradit
gold
standard
routin
diagnosi
viral
respiratori
agent
howev
method
labori
time
consum
although
immunofluoresc
antibodi
test
easi
perform
antigen
detect
less
sensit
specif
bellaupujol
et
al
landri
ferguson
current
tradit
cell
cultur
ifat
techniqu
diagnosi
identif
viral
respiratori
agent
replac
gradual
molecular
techniqu
pcr
increas
diagnost
accuraci
routin
assay
decreas
turnaround
time
result
coria
et
al
henrickson
syrmi
et
al
short
result
turnov
time
import
viral
outbreak
case
sever
infect
patient
initi
antivir
therapi
time
adcock
et
al
coria
et
al
woo
et
al
thu
present
studi
aim
compar
multiplex
revers
transcriptas
polymeras
chain
reaction
follow
chip
hybrid
assay
h
result
turnaround
time
combin
shell
vial
cell
cultur
ifat
total
day
turnaround
time
result
rsv
influenza
virus
major
viral
agent
caus
respiratori
ill
pediatr
adult
patient
respect
henrickson
weigl
et
al
studi
parainfluenza
viru
type
adenovirusparainfluenza
viru
type
major
viral
agent
detect
pediatr
adult
patient
specimen
respect
parainfluenza
viru
type
frequent
isol
pediatr
patient
research
specimen
use
studi
collect
parainfluenza
viru
type
outbreak
report
municip
turkey
decemb
march
et
al
present
studi
combin
shell
vial
cell
cultur
ifat
detect
nine
dual
infect
compar
prodect
bc
rv
chip
detect
one
dual
infect
two
studi
publish
previous
larg
number
dual
infect
detect
multiplex
rtpcr
compar
tradit
diagnost
assay
bellaupujol
et
al
coria
et
al
thu
prodect
bc
rv
chip
consid
suitabl
detect
dual
infect
howev
shell
vial
cell
cultur
use
studi
could
detect
rsv
four
case
dual
infect
caus
rsv
parainfluenza
viru
type
ifat
detect
rsv
specimen
report
previou
studi
reason
discrep
might
due
rapid
loss
viabil
rsv
unsuit
transport
andor
storag
condit
previou
studi
compar
multiplex
rtpcr
tradit
respiratori
viru
diagnost
assay
shell
vial
cell
cultur
ifat
andor
individu
rtpcr
report
often
multiplex
pcr
sensit
specif
detect
respiratori
virus
bellaupujol
et
al
coria
et
al
liolio
et
al
syrmi
et
al
studi
liolio
et
al
use
nucleocapsid
hemagglutininneuraminidas
gene
region
rsv
parainfluenza
viru
type
respect
bellaupujol
et
al
use
nucleocapsid
hemagglutininneuraminidas
gene
region
rsv
parainfluenza
viru
type
respect
syrmi
et
al
use
nucleocapsid
hexon
protein
l
protein
parainfluenza
viru
type
adenoviru
rsv
respect
coria
et
al
use
fusion
protein
hexon
protein
hemagglutinin
gene
region
rsv
adenoviru
parainfluenza
viru
type
respect
howev
two
studi
et
al
pupp
et
al
report
multiplex
rtpcr
less
sensit
detect
rsv
parainfluenza
viru
type
among
test
pathogen
compar
tradit
diagnost
assay
studi
subunit
fusion
glycoprotein
gene
noncod
region
fusion
protein
hexon
gene
region
use
detect
rsv
parainfluenza
viru
type
adenoviru
respect
et
al
pupp
et
al
similar
two
studi
prodect
bc
rv
chip
also
less
sensit
detect
rsv
adenoviru
parainfluenza
viru
type
compar
shell
vial
cell
cultur
ifat
prodect
bc
rv
chip
use
nonstructur
gene
hemagglutinin
hemagglutininneuraminidas
gene
region
detect
rsv
adenoviru
parainfluenza
viru
type
respect
prodect
bc
rv
chip
gene
region
detect
rsv
adenoviru
use
first
time
literatur
therefor
reason
low
sensit
obtain
detect
rsv
adenoviru
prodect
bc
rv
chip
might
due
select
primer
gene
region
differ
studi
describ
previous
high
sensit
virus
pupp
et
al
report
low
sensit
parainfluenza
viru
type
use
noncod
region
fusion
protein
gene
region
multiplex
rtpcr
elisa
method
compar
tradit
diagnost
assay
previou
studi
detect
parainfluenza
viru
type
high
sensit
use
mainli
hemagglutininneuraminidas
nucleocapsid
gene
region
multiplex
rtpcr
bellaupujol
et
al
coria
et
al
liolio
et
al
syrmi
et
al
prodect
bc
rv
chip
also
use
hemagglutininneuraminidas
gene
region
detect
parainfluenza
viru
type
howev
less
sensit
compar
combin
shell
vial
cell
cultur
ifat
order
investig
technic
problem
sampl
error
loss
rna
extract
degrad
rna
might
caus
prodect
bc
rv
chip
low
sensit
detect
parainfluenza
viru
type
capvir
assay
appli
randomli
select
specimen
parainfluenza
viru
type
posit
shell
vial
cell
cultur
neg
prodect
bc
rv
chip
assay
result
capvir
detect
parainfluenza
viru
type
posit
specimen
detect
prodect
bc
rv
chip
elimin
presenc
technic
problem
describ
anoth
paramet
caus
decreas
sensit
might
select
primer
gene
region
differ
recommend
one
howev
capvir
prodect
bc
rv
chip
use
recommend
nucleocapsid
hemagglutininneuraminidas
gene
region
respect
detect
parainfluenza
viru
type
anoth
paramet
import
applic
multiplex
rtpcr
larg
number
primer
set
combin
singl
reaction
hamper
sensit
assay
syrmi
et
al
interestingli
studi
report
high
sensit
detect
respiratori
virus
multiplex
rtpcr
prodect
bc
rv
chip
use
high
number
primer
set
combin
singl
reaction
except
multiplex
rtpcr
develop
capvir
use
low
number
primer
three
set
primer
mix
method
mix
primer
parainfluenza
viru
type
tube
contain
low
number
prime
set
bellaupujol
et
al
coria
et
al
liolio
et
al
syrmi
et
al
inadequ
optim
larg
number
primer
set
singl
reaction
might
caus
low
sensit
prodect
bc
rv
chip
detect
parainfluenza
viru
type
although
prodect
bc
rv
chip
decreas
sensit
routin
laboratori
use
describ
high
ppv
specif
absenc
crossreact
virus
fals
posit
result
overal
prodect
bc
rv
chip
high
specif
design
primer
gene
region
reaction
larg
number
primer
set
still
need
optim
routin
laboratori
use
result
prodect
bc
rv
chip
low
sensit
compar
combin
shell
vial
cell
cultur
ifat
consid
gold
standard
present
studi
